Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Headline
This research programme on dementia care found neither staff training with on-line decision support interventions in care homes, nor treatment from NHS teams in the community, reduced clinically significant challenging behaviour
Abstract
Background:
Dementia with challenging behaviour (CB) causes significant distress for caregivers and the person with dementia. It is associated with breakdown of care at home and disruption in care homes. Challenge Demcare aimed to assist care home staff and mental health practitioners who support families at home to respond effectively to CB.
Objectives:
To study the management of CB in care homes (ResCare) and in family care (FamCare). Following a conceptual overview, two systematic reviews and scrutiny of clinical guidelines, we (1) developed and tested a computerised intervention; (2) conducted a cluster randomised trial (CRT) of the intervention for dementia with CB in care homes; (3) conducted a process evaluation of implementation of the intervention; and (4) conducted a longitudinal observational cohort study of the management of people with dementia with CB living at home, and their carers.
Review methods:
Cochrane review of randomised controlled trials; systematic meta-ethnographic review of quantitative and qualitative studies.
Design:
ResCare – survey, CRT, process evaluation and stakeholder consultations. FamCare – survey, longitudinal cohort study, participatory development design process and stakeholder consultations. Comparative examination of baseline levels of CB in the ResCare trial and the FamCare study participants.
Settings:
ResCare – 63 care homes in Yorkshire. FamCare – 33 community mental health teams for older people (CMHTsOP) in seven NHS organisations across England.
Participants:
ResCare – 2386 residents and 861 staff screened for eligibility; 555 residents with dementia and CB; 277 ‘other’ residents; 632 care staff; and 92 staff champions. FamCare – every new referral (n = 5360) reviewed for eligibility; 157 patients with dementia and CB, with their carer; and 26 mental health practitioners. Stakeholder consultations – initial workshops with 83 practitioners and managers from participating organisations; and 70 additional stakeholders using eight group discussions and nine individual interviews.
Intervention:
An online application for case-specific action plans to reduce CB in dementia, consisting of e-learning and bespoke decision support care home and family care e-tools.
Main outcome measures:
ResCare – survey with the Challenging Behaviour Scale; measurement of CB with the Neuropsychiatric Inventory (NPI) and medications taken from prescriptions; implementation with thematic views from participants and stakeholders. FamCare – case identification from all referrals to CMHTsOP; measurement of CB with the Revised Memory and Behaviour Problems Checklist and NPI; medications taken from prescriptions; and thematic views from stakeholders. Costs of care calculated for both settings. Comparison of the ResCare trial and FamCare study participants used the NPI, Clinical Dementia Rating and prescribed medications.
Results:
ResCare – training with group discussion and decision support for individualised interventions did not change practice enough to have an impact on CB in dementia. Worksite e-learning opportunities were not readily taken up by care home staff. Smaller homes with a less hierarchical management appear more ready than others to engage in innovation. FamCare – home-dwelling people with dementia and CB are referred to specialist NHS services, but treatment over 6 months, averaging nine contacts per family, had no overall impact on CB. Over 60% of people with CB had mild dementia. Families bear the majority of the care costs of dementia with CB. A care gap in the delivery of post-diagnostic help for families supporting relatives with dementia and significant CB at home has emerged. Higher levels of CB were recorded in family settings; and prescribing practices were suboptimal in both care home and family settings.
Limitations:
Functionality of the software was unreliable, resulting in delays. This compromised the feasibility studies and undermined delivery of the intervention in care homes. A planned FamCare CRT could not proceed because of insufficient referrals.
Conclusions:
A Cochrane review of individualised functional analysis-based interventions suggests that these show promise, although delivery requires a trained dementia care workforce. Like many staff training interventions, our interactive e-learning course was well received by staff when delivered in groups with facilitated discussion. Our e-learning and decision support e-tool intervention in care homes, in its current form, without ongoing review of implementation of recommended action plans, is not effective at reducing CB when compared with usual care. This may also be true for staff training in general. A shift in priorities from early diagnosis to early recognition of dementia with clinically significant CB could bridge the emerging gap and inequities of care to families. Formalised service improvements in the NHS, to co-ordinate such interventions, may stimulate better opportunities for practice models and pathways. Separate services for care homes and family care may enhance the efficiency of delivery and the quality of research on implementation into routine care.
Future work:
There is scope for extending functional analysis-based interventions with communication and interaction training for carers. Our clinical workbooks, video material of real-life episodes of CB and process evaluation tool resources require further testing. There is an urgent need for evaluation of interventions for home-dwelling people with dementia with clinically significant CB, delivered by trained dementia practitioners. Realist evaluation designs may illuminate how the intervention might work, and for whom, within varying service contexts.
Trial registration:
Current Controlled Trials ISRCTN02553381 (the ResCare trial) and ISRCTN58876649 (the FamCare study).
Funding:
This project was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 5, No. 15. See the NIHR Journals Library website for further project information.
Contents
- Plain English summary
- Scientific summary
- Chapter 1. Introduction and background
- Chapter overview
- Definition of challenging behaviour in dementia
- Management of challenging behaviour in dementia
- Elusiveness of the syndrome: aetiology and other contextual factors
- Implications for methodology
- Rationale for current study
- Functional analysis-based interventions
- Challenge Demcare
- Literature reviews on the management of challenging behaviour in dementia
- Outline of studies within Challenge Demcare: Chapters 2–6
- Chapter 2. Development and testing of an online application of functional analysis approaches to intervention for challenging behaviour in dementia
- Chapter 3. Challenge ResCare: a cluster randomised trial of the clinical effectiveness and cost-effectiveness of online training and decision support for care home staff to deliver functional analysis-based interventions for challenging behaviour in dementia
- Chapter 4. Challenge ResCare: a process evaluation of the implementation of e-tools for the management of dementia with challenging behaviour in care homes
- Chapter 5. Challenge FamCare: a naturalistic study of people with dementia and challenging behaviour living at home and their carers
- Chapter 6. Discussion: overview of key findings from Challenge Demcare and implications for future research and practice
- Overview of Challenge Demcare
- Chapter outline
- Key findings
- Limitations
- Implications for research methodology
- Challenging behaviour in dementia care home and family care settings: a comparison of clinical presentations
- Discussion: the management of challenging behaviour in dementia
- Implications for service improvements and practice
- Recommendations for future research
- Conclusions
- Acknowledgements
- References
- Appendix 1. Description of the e-learning and decision support tool
- Appendix 2. The FamCare study: changes to protocol
- Appendix 3. The FamCare study: summary of the recruitment context
- Appendix 4. The ResCare trial: ethical permissions
- Appendix 5. Management of the research
- Appendix 6. Measures
- Appendix 7. Unit costs and sources
- Appendix 8. ResCare: factors affecting resident and staff dropout
- Appendix 9. The ResCare trial: tables relating to the analysis of the dose effect of the intervention
- Appendix 10. The ResCare trial: analysis of residents with inpatient stays
- Appendix 11. The ResCare trial: breakdown of resource use and costs in the 4 months up to follow-up
- Appendix 12. The FamCare study: ethical permissions
- Appendix 13. The FamCare study: reasons for declining participation
- Appendix 14. The FamCare study: results of the backward regression analysis (using the data set after the 25% missing rule for predictors of change)
- Appendix 15. The FamCare study service use frequencies and costs for participants with data recorded at all time points
- Appendix 16. The FamCare study service use frequencies and costs for all participants available at each of the individual time points
- Appendix 17. The FamCare study: mean monthly frequencies of health- and social-care contacts for participants with data recorded at all time points
- Appendix 18. The FamCare study: alternative accommodation
- Appendix 19. The FamCare study: medication prescribing for people with dementia in the 3 months before baseline (whole sample)
- Appendix 20. Comparisons of the ResCare trial and the FamCare study
- List of abbreviations
About the Series
Article history
The research reported in this issue of the journal was funded by PGfAR as project number RP-PG-0606-1067. The contractual start date was in August 2007. The final report began editorial review in January 2016 and was accepted for publication in February 2017. As the funder, the PGfAR programme agreed the research questions and study designs in advance with the investigators. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The PGfAR editors and production house have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the final report document. However, they do not accept liability for damages or losses arising from material published in this report.
Declared competing interests of authors
none
Last reviewed: January 2016; Accepted: February 2017.
- NLM CatalogRelated NLM Catalog Entries
- Review Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs[ 2020]Review Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTsBallard C, Orrell M, Moniz-Cook E, Woods R, Whitaker R, Corbett A, Aarsland D, Murray J, Lawrence V, Testad I, et al. 2020 Jul
- Review Strategies for older people living in care homes to prevent urinary tract infection: the StOP UTI realist synthesis.[Health Technol Assess. 2024]Review Strategies for older people living in care homes to prevent urinary tract infection: the StOP UTI realist synthesis.Prieto J, Wilson J, Tingle A, Cooper E, Handley M, Rycroft-Malone J, Bostock J, Williams L, Loveday H. Health Technol Assess. 2024 Oct; 28(68):1-139.
- Review Strategies to enhance routine physical activity in care home residents: the REACH research programme including a cluster feasibility RCT[ 2021]Review Strategies to enhance routine physical activity in care home residents: the REACH research programme including a cluster feasibility RCTForster A, Godfrey M, Green J, McMaster N, Airlie J, Cundill B, Lawton R, Hawkins R, Hulme C, Birch K, et al. 2021 Aug
- Reducing unplanned hospital admissions from care homes: a systematic review.[Health Soc Care Deliv Res. 2023]Reducing unplanned hospital admissions from care homes: a systematic review.Chambers D, Cantrell A, Preston L, Marincowitz C, Wright L, Conroy S, Lee Gordon A. Health Soc Care Deliv Res. 2023 Oct; 11(18):1-130.
- A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.[Health Technol Assess. 2020]A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.Froggatt K, Best A, Bunn F, Burnside G, Coast J, Dunleavy L, Goodman C, Hardwick B, Jackson C, Kinley J, et al. Health Technol Assess. 2020 Jan; 24(6):1-140.
- Challenge Demcare: management of challenging behaviour in dementia at home and i...Challenge Demcare: management of challenging behaviour in dementia at home and in care homes – development, evaluation and implementation of an online individualised intervention for care homes; and a cohort study of specialist community mental health care for families
- Twins (6)MeSH
- CDK11B cyclin dependent kinase 11B [Homo sapiens]CDK11B cyclin dependent kinase 11B [Homo sapiens]Gene ID:984Gene
- 984[uid] AND (alive[prop]) (1)Gene
- RecName: Full=Galanin peptides; Contains: RecName: Full=Galanin; Contains: RecNa...RecName: Full=Galanin peptides; Contains: RecName: Full=Galanin; Contains: RecName: Full=Galanin message-associated peptide; Short=GMAP; Flags: Precursorgi|120918|sp|P07480.1|GALA_PIGProtein
Your browsing activity is empty.
Activity recording is turned off.
See more...